Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Otsuka discovers new platelet aggregation inhibitors and antithrombotic agents

Feb. 1, 1999

U.K. launch announced for hemophilia B treatment

Jan. 29, 1999

Searle drops development of gpIIb/IIIa receptor antagonists

Jan. 25, 1999

Potent heterocyclic antithrombotic agents discovered by Lilly

Jan. 25, 1999

Integrin receptor antagonists, prodrugs and transdermal iontophoretic administration

Jan. 22, 1999

DuPont presents potent, orally active antiplatelet agent with good duration of action

Jan. 21, 1999

New market introduction for Organon's anticoagulant

Jan. 20, 1999

Oral heparin shown equivalent in efficacy and safety to injectable heparin

Jan. 19, 1999

Z-335 characterized as potent, orally effective and long-acting antiplatelet/antithrombotic agent

Jan. 19, 1999

Beraprost to enter clinical trials in North America

Jan. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...